Comparison of Intensity- and Polarization-based Contrast in Amyloid-beta Plaques as Observed by Optical Coherence Tomography

One key hallmark of Alzheimer’s disease (AD) is the accumulation of extracellular amyloid-beta protein in cortical regions of the brain. For a definitive diagnosis of AD, post-mortem histological analysis, including sectioning and staining of different brain regions, is required. Here, we present optical coherence tomography (OCT) as a tissue-preserving imaging modality for the visualization of amyloid-beta plaques and compare their contrast in intensity- and polarization-sensitive (PS) OCT. Human brain samples of eleven patients diagnosed with AD were imaged. Three-dimensional PS-OCT datasets were acquired and plaques were manually segmented in 500 intensity and retardation cross-sections per patient using the freely available ITK-SNAP software. The image contrast of plaques was quantified. Histological staining of tissue sections from the same specimens was performed to compare OCT findings against the gold standard. Furthermore, the distribution of plaques was evaluated for intensity-based OCT, PS-OCT and the corresponding histological amyloid-beta staining. Only 5% of plaques were visible in both intensity and retardation segmentations, suggesting that different types of plaques may be visualized by the two OCT contrast channels. Our results indicate that multicontrast OCT imaging might be a promising approach for a tissue-preserving visualization of amyloid-beta plaques in AD.

[1]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[2]  Marco Augustin,et al.  Assessment of pathological features in Alzheimer’s disease brain tissue with a large field-of-view visible-light optical coherence microscope , 2018, Neurophotonics.

[3]  K. Scheffler,et al.  Three-dimensional strain fields in human brain resulting from formalin fixation , 2011, Journal of Neuroscience Methods.

[4]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[5]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[6]  D. Salmon,et al.  Alzheimer’s Disease: Past, Present, and Future , 2017, Journal of the International Neuropsychological Society.

[7]  Theo Lasser,et al.  Visible spectrum extended-focus optical coherence microscopy for label-free sub-cellular tomography. , 2017, Biomedical optics express.

[8]  J. Fujimoto,et al.  Polarization-sensitive low-coherence reflectometer for birefringence characterization and ranging , 1992 .

[9]  J. Morrison,et al.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. , 1987, Science.

[10]  Christoph K. Hitzenberger,et al.  Spectroscopic imaging with spectral domain visible light optical coherence microscopy in Alzheimer’s disease brain samples , 2017, Biomedical optics express.

[11]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[12]  D Thomas,et al.  Optical coherence tomography—a review of the principles and contemporary uses in retinal investigation , 2004, Eye.

[13]  Jon Holmes,et al.  Advances in optical coherence tomography in dermatology—a review , 2018, Journal of biomedical optics.

[14]  Adam Boretsky,et al.  Image quality metrics for optical coherence angiography. , 2015, Biomedical optics express.

[15]  B Ostertun,et al.  Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment. , 1996, Dementia.

[16]  Marc Dhenain,et al.  Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer’s disease brains , 2017, Scientific Reports.

[17]  C. Hitzenberger,et al.  Polarization sensitive optical coherence tomography - a review [Invited]. , 2017, Biomedical optics express.

[18]  P. Roller,et al.  Formaldehyde fixation. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  Philip T Cagle,et al.  The 100-year anniversary of the description of the frozen section procedure. , 2005, JAMA.

[20]  D. Westaway,et al.  Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.

[21]  J. Morrison,et al.  Life and death of neurons in the aging brain. , 1997, Science.

[22]  Alzheimer's Association∗ 2019 Alzheimer's disease facts and figures , 2019, Alzheimer's & Dementia.

[23]  T Iwadare,et al.  Dimensional changes of tissues in the course of processing , 1984, Journal of microscopy.

[24]  R. Leitgeb,et al.  Speckle noise reduction in high speed polarization sensitive spectral domain optical coherence tomography. , 2011, Optics express.

[25]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[26]  D. L. Taylor,et al.  DETERMINATION OF THE POLARIZATION OPTICAL PROPERTIES OF THE AMYLOID-CONGO RED COMPLEX BY PHASE MODULATION MICROSPECTROPHOTOMETRY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  Susan Mallett,et al.  Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. , 2016, The Cochrane database of systematic reviews.

[28]  L. Schneider,et al.  Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.

[29]  Christoph K. Hitzenberger,et al.  Visualization of neuritic plaques in Alzheimer’s disease by polarization-sensitive optical coherence microscopy , 2017, Scientific Reports.

[30]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[31]  K Namekata,et al.  Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. , 1998, The American journal of pathology.

[32]  Michael Unser,et al.  A pyramid approach to subpixel registration based on intensity , 1998, IEEE Trans. Image Process..

[33]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[34]  Christoph K. Hitzenberger,et al.  Beyond backscattering: optical neuroimaging by BRAD , 2017, Biomedical optics express.

[35]  J. Hardy,et al.  Alzheimer's disease , 2018, European journal of neurology.

[36]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[37]  M. Villiger,et al.  Label-Free Imaging of Cerebral β-Amyloidosis with Extended-Focus Optical Coherence Microscopy , 2012, The Journal of Neuroscience.

[38]  A. Fercher,et al.  Optical coherence tomography - principles and applications , 2003 .

[39]  G. Glenner,et al.  Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[40]  G. Keiser,et al.  Advanced Optical Methods for Brain Imaging , 2019, Progress in Optical Science and Photonics.

[41]  Bart Kahr,et al.  Imaging linear birefringence and dichroism in cerebral amyloid pathologies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Sage C. Arbor,et al.  Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores , 2016, The Yale journal of biology and medicine.

[43]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[44]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[45]  Michalina J Gora,et al.  Endoscopic optical coherence tomography: technologies and clinical applications [Invited]. , 2017, Biomedical optics express.